Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

LRMR holding history

Larimar Therapeutics, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LRMR overviewAll 13F holders of LRMRFull Q2 2026 holdings

Shares (Q2 2026)
1,456,825
Value
$4.44M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of LRMR by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,456,825$4.44M<0.1%+937,693+180.6%AddedHolders
Q1 2026519,132$2.34M<0.1%−847,618−62.0%ReducedHolders
Q4 20251,366,750$5.21M<0.1%−110,756−7.5%ReducedHolders
Q3 20251,477,506$4.77M<0.1%+141,251+10.6%AddedHolders
Q2 20251,336,255$3.86M<0.1%+901,969+207.7%AddedHolders
Q1 2025434,286$933.7K<0.1%+434,286NewHolders
Q4 20240$00.0%−38,807−100.0%Sold outHolders
Q3 202438,807$254.2K<0.1%+34,618+826.4%AddedHolders
Q2 20244,189$30.4K<0.1%−1,160,070−99.6%ReducedHolders
Q1 20241,164,259$8.84M<0.1%+481,900+70.6%AddedHolders
Q4 2023682,359$3.10M<0.1%−296,827−30.3%ReducedHolders
Q3 2023979,186$3.87M<0.1%−197,469−16.8%ReducedHolders
Q2 20231,176,655$3.68M<0.1%+500,217+73.9%AddedHolders
Q1 2023676,438$3.06M<0.1%+116,071+20.7%AddedHolders
Q4 2022560,367$2.31M<0.1%+544,766+3,491.9%AddedHolders
Q3 202215,601$50.0K<0.1%+1,925+14.1%AddedHolders
Q2 202213,676$27.0K<0.1%+779+6.0%AddedHolders
Q1 202212,897$52.0K<0.1%+12,897NewHolders
Q4 20210$00.0%−309,260−100.0%Sold outHolders
Q3 2021309,260$3.57M<0.1%+1,117+0.4%AddedHolders
Q2 2021308,143$3.03M<0.1%+295,773+2,391.1%AddedHolders
Q1 202112,370$181.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.